Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00676897 · ClinicalTrials.gov registry record · Phase 2
Statin Therapy in the Treatment of Sepsis
A Phase 2 study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 18
- Enrollment target
NCT00676897 is a Phase 2 study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 18 participants.
The verdict
NCT00676897, a Phase 2 study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 18 participants
- Enrollment target
Study Summary
Simvastatin will attenutat IL-6 levels and lead to a more rapid shock reversal than placebo
Interventions
- DRUG Placebo
- DRUG Simvastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2008-02 |
| Est. Completion | 2010-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00676897
The ClinicalTrials.gov registry entry for NCT00676897 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00676897 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00676897 about?
NCT00676897 is a clinical study titled "Statin Therapy in the Treatment of Sepsis". Simvastatin will attenutat IL-6 levels and lead to a more rapid shock reversal than placebo
What is the current status of trial NCT00676897?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 18 participants. The study started on 2008-02. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00676897?
The interventions under investigation include: Placebo (DRUG), Simvastatin (DRUG).
Who is sponsoring clinical trial NCT00676897?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.